Shenzhen YHLO Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Shenzhen YHLO Biotech has a total shareholder equity of CN¥2.6B and total debt of CN¥579.6M, which brings its debt-to-equity ratio to 22.4%. Its total assets and total liabilities are CN¥3.9B and CN¥1.3B respectively. Shenzhen YHLO Biotech's EBIT is CN¥181.0M making its interest coverage ratio -1.5. It has cash and short-term investments of CN¥653.3M.
Key information
22.4%
Debt to equity ratio
CN¥579.64m
Debt
| Interest coverage ratio | -1.5x |
| Cash | CN¥653.29m |
| Equity | CN¥2.59b |
| Total liabilities | CN¥1.27b |
| Total assets | CN¥3.86b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688575's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥792.1M).
Long Term Liabilities: 688575's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥480.5M).
Debt to Equity History and Analysis
Debt Level: 688575 has more cash than its total debt.
Reducing Debt: 688575's debt to equity ratio has reduced from 60.2% to 22.4% over the past 5 years.
Debt Coverage: 688575's debt is well covered by operating cash flow (61.9%).
Interest Coverage: 688575 earns more interest than it pays, so coverage of interest payments is not a concern.